Molina Healthcare (NYSE:MOH) Reaches New 52-Week Low – What’s Next?

Molina Healthcare, Inc. (NYSE:MOH)’s stock price hit a new 52-week low on Tuesday . The company traded as low as $282.45 and last traded at $282.86, with a volume of 374071 shares trading hands. The stock had previously closed at $286.60.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft dropped their price objective on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research note on Monday, July 29th. Jefferies Financial Group decreased their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a report on Wednesday, July 24th. Robert W. Baird reduced their price target on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research report on Thursday. StockNews.com upgraded Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $371.83.

Molina Healthcare Stock Up 14.6 %

The firm has a market capitalization of $18.46 billion, a P/E ratio of 16.77, a PEG ratio of 1.15 and a beta of 0.58. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.57 and a current ratio of 1.57. The firm’s 50-day moving average is $336.17 and its 200 day moving average is $330.51.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, beating analysts’ consensus estimates of $5.73 by $0.13. The company had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The company’s quarterly revenue was up 18.7% compared to the same quarter last year. During the same period in the previous year, the company posted $5.65 earnings per share. As a group, equities research analysts predict that Molina Healthcare, Inc. will post 23.5 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares of the company’s stock, valued at $6,114,260.25. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the sale, the chief accounting officer now directly owns 9,473 shares in the company, valued at approximately $3,282,583.96. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.

Institutional Trading of Molina Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of MOH. Innealta Capital LLC acquired a new position in shares of Molina Healthcare during the 2nd quarter worth approximately $36,000. Ashton Thomas Private Wealth LLC bought a new position in shares of Molina Healthcare in the second quarter valued at $40,000. AM Squared Ltd acquired a new position in Molina Healthcare during the second quarter worth $59,000. UMB Bank n.a. raised its position in Molina Healthcare by 96.2% during the third quarter. UMB Bank n.a. now owns 206 shares of the company’s stock worth $71,000 after acquiring an additional 101 shares in the last quarter. Finally, Fidelis Capital Partners LLC acquired a new stake in Molina Healthcare in the first quarter valued at $151,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.